Lumiata, a San Mateo, CA-based AI-powered predictive analytics company, raised $10m in funding.
The round was led by Intel Capital with participation from existing investors Blue Cross Blue Shield Venture Partners, Sandbox Industries, and Khosla Ventures.
The company has raised $20m in total funding.
Founded in 2013 by Ash Damle, CEO, Lumiata is a predictive analytics company that leverages medical artificial intelligence to enable health organizations to manage risk and prioritize care.
The Lumiata Medical Graph analyzes hundreds of healthcare data sets within the context of clinical practice and medical knowledge, and maps out insights on current and future health trajectories of individuals.
The Graph is comprised of more than 260 million data points, 4TB of structured and unstructured medical knowledge and 35,000 hours of physician review.
The company’s technology is used by a number of leading organizations, including Universal American, Google, and a major BlueCross plan.